94 related articles for article (PubMed ID: 3950414)
1. Monoclonal antibody 45-2D9 conjugated to the A chain of ricin is specifically toxic to c-Ha-ras-transfected NIH 3T3 cells expressing gp74.
Roth JA; Ames RS; Byers V; Lee HM; Scannon PJ
J Immunol; 1986 Mar; 136(6):2305-10. PubMed ID: 3950414
[TBL] [Abstract][Full Text] [Related]
2. Analysis of gp74 expression by transformed rat fibroblasts from experimental pulmonary metastases following specific ricin A-chain immunotoxin therapy.
Roth JA; Thomsen S; Fry KD; Scannon P; Chang C
Cancer Res; 1989 Oct; 49(20):5708-12. PubMed ID: 2676148
[TBL] [Abstract][Full Text] [Related]
3. Mediation of reduction of spontaneous and experimental pulmonary metastases by ricin A-chain immunotoxin 45-2D9-RTA with potentiation by systemic monensin in mice.
Roth JA; Ames RS; Fry K; Lee HM; Scannon PJ
Cancer Res; 1988 Jun; 48(12):3496-501. PubMed ID: 3259469
[TBL] [Abstract][Full Text] [Related]
4. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody 45-2D9 recognizes a cell surface glycoprotein on a human c-Ha-ras transformed cell line (45-342) and a shared epitope on human tumors.
Roth JA; Ames RS; Restrepo C; Scuderi P
J Immunol; 1986 Oct; 137(7):2385-9. PubMed ID: 3531330
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
Weil-Hillman G; Runge W; Jansen FK; Vallera DA
Cancer Res; 1985 Mar; 45(3):1328-36. PubMed ID: 3971376
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B
J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
[TBL] [Abstract][Full Text] [Related]
8. Analysis of expression of cell surface antigen Mr 74,000 phosphoglycoprotein in normal, oncogene-transformed, and neoplastic rat cell lines.
Ames RS; North SM; Fry KD; Tainsky MA; Nicolson GL; Roth JA
Cancer Res; 1989 May; 49(9):2312-9. PubMed ID: 2650864
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hematopoietic progenitor colony growth by a monoclonal antibody against the transferrin receptor: comparison of unconjugated antibody with an immunotoxin containing recombinant ricin A chain.
Shannon KM; Ring DB; Houston LL; Schaffner V; Naylor J; Torkildson JC; Reid SA; Larrick J
Int J Cell Cloning; 1990 Sep; 8(5):368-76. PubMed ID: 2230286
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents.
Byers VS; Pimm MV; Pawluczyk IZ; Lee HM; Scannon PJ; Baldwin RW
Cancer Res; 1987 Oct; 47(20):5277-83. PubMed ID: 3498532
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates.
Byers VS; Pimm MV; Scannon PJ; Pawluczyk I; Baldwin RW
Cancer Res; 1987 Oct; 47(19):5042-6. PubMed ID: 3497715
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer.
Calvete JA; Newell DR; Wright AF; Rose MS
Cancer Res; 1994 Sep; 54(17):4684-90. PubMed ID: 8062265
[TBL] [Abstract][Full Text] [Related]
15. Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action.
Byers VS; Pawluczyk IZ; Hooi DS; Price MR; Carroll S; Embleton MJ; Garnett MC; Berry N; Robins RA; Baldwin RW
Cancer Res; 1991 Apr; 51(8):1990-5. PubMed ID: 2009518
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.
Byers VS; Rodvien R; Grant K; Durrant LG; Hudson KH; Baldwin RW; Scannon PJ
Cancer Res; 1989 Nov; 49(21):6153-60. PubMed ID: 2790828
[TBL] [Abstract][Full Text] [Related]
17. Combined immunochemotherapy of human solid tumors in nude mice.
Weil-Hillman G; Uckun FM; Manske JM; Vallera DA
Cancer Res; 1987 Jan; 47(2):579-85. PubMed ID: 3491678
[TBL] [Abstract][Full Text] [Related]
18. An immunotoxin cytotoxic for breast cancer cells in vitro.
LeMaistre CF; Edwards DP; Krolick KA; McGuire WL
Cancer Res; 1987 Feb; 47(3):730-4. PubMed ID: 3492266
[TBL] [Abstract][Full Text] [Related]
19. A novel approach to production of antitumor monoclonal antibodies: antibody to a cell surface glycoprotein associated with transformation by a human oncogene.
Roth JA; Scuderi P; Westin E; Gallo RC
Surgery; 1984 Aug; 96(2):264-72. PubMed ID: 6379959
[TBL] [Abstract][Full Text] [Related]
20. Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.
Durrant LG; Byers VS; Scannon PJ; Rodvien R; Grant K; Robins RA; Marksman RA; Baldwin RW
Clin Exp Immunol; 1989 Feb; 75(2):258-64. PubMed ID: 2784738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
